Deferasirox Tablets USP

Pharmacies, wholesalers, and distributors that stock iron chelation therapy need a product they can dispense with confidence and reorder without disruption. Deferasirox Tablets USP from Xiromed answers that need. This oral iron chelator gives your inventory a dependable option backed by consistent manufacturing, clear specifications, and a practical bottle count that fits real dispensing patterns.

Product Overview

Deferasirox Tablets USP is an oral iron chelation therapy supplied at a strength of 90 mg per tablet. Each bottle holds 30 tablets, giving your team a compact, easy-to-manage count that maps cleanly to a range of dispensing needs. The 30-count bottle keeps reorder rhythms predictable and helps pharmacy staff manage stock without excess handling.

The product carries NDC 70700-269-30, so buyers can verify the exact configuration before placing an order and match it accurately against inventory systems. Each tablet delivers a fixed 90 mg dose of the active ingredient, which removes guesswork and helps pharmacists dispense with precision.

For distributors building out an iron chelation or hematology-support category, Deferasirox Tablets USP slots in cleanly. It fills a recognized therapeutic need, ships in a standard bottle count, and arrives with the documentation your compliance and procurement teams expect from a reliable supplier. The USP designation signals that the product is formulated to recognized United States Pharmacopeia standards, giving buyers added assurance around quality and identity.

Active Ingredient and Its Role

The value of this product rests on a single, well-established active ingredient.

Deferasirox is an orally active iron chelating agent. In patients who receive frequent blood transfusions, iron can accumulate in the body over time, since the body has no efficient way to remove excess iron on its own. Deferasirox works by binding to that excess iron so it can be eliminated, helping to manage chronic iron overload.

Delivered as an oral tablet, Deferasirox offers a convenient administration route compared with older chelation approaches. Because the tablet supplies the active ingredient in a fixed, standardized 90 mg concentration, pharmacists dispense with precision and prescribers can rely on consistent product from one order to the next. This targeted, predictable dosing supports both adherence and straightforward day-to-day pharmacy operations.

Indications and Use

Deferasirox Tablets USP is an oral iron chelation therapy intended for use under the direction of a qualified healthcare professional. Products in this category are typically prescribed to help manage chronic iron overload, including iron overload associated with regular blood transfusions in appropriate patients.

Prescribing decisions, dosing, patient selection, monitoring, and treatment duration should always follow the approved product labeling and the clinical judgment of the treating physician. Because iron chelation therapy requires ongoing monitoring, treatment should proceed only under proper clinical supervision. This description is written for licensed professionals and authorized trade partners and does not replace the full prescribing information. Always confirm indications, contraindications, and directions against the current labeling before dispensing.

Pack Configuration and Key Details

Clear specifications reduce ordering errors and keep procurement moving. Confirm the following before adding Deferasirox Tablets USP to your catalog:

• Product name: Deferasirox Tablets USP
• Active ingredient: Deferasirox
• Strength: 90 mg per tablet
• Pack size: 30 Count Bottle
• NDC: 70700-269-30
• Dosage form: Oral tablet
• Category: Iron chelation therapy
• Supplier: Xiromed

The 30-count bottle gives you a manageable unit for stocking and reordering. Verify the NDC against your systems before each order to keep shipments matched and your reorder pattern clean.

Why Source Through Xiromed

Reliable supply matters as much as the product itself. Xiromed manufactures its portfolio to meet stringent regulatory standards, and Deferasirox Tablets USP holds to the same benchmark. Each batch is produced with consistency in mind, so your supply chain receives a product that performs the same way order after order.

Sourcing Deferasirox Tablets USP directly through Xiromed gives buyers verified specifications, a confirmed NDC for accurate matching, and a supply relationship built around the demands of pharmacies and distributors. When availability and documentation both matter, working with a manufacturer that prioritizes each makes procurement simpler.

If you are expanding your iron chelation offering or securing a steady source for an existing line, Deferasirox Tablets USP is a straightforward addition. To order or request further product information, connect with the Xiromed team and reference NDC 70700-269-30 to confirm the exact 90 mg, 30 Count Bottle configuration for your inventory.

This information is intended for licensed healthcare professionals, pharmacies, and authorized distributors. Deferasirox Tablets USP is a prescription product and should be used only as directed by a qualified healthcare provider in accordance with the approved product labeling. Product availability, specifications, and regulatory status may vary by region. Refer to the full prescribing information before dispensing.